Crinetics Pharmaceuticals, Inc.: Form 8-K filed 2026-09-01
- Accepted by EDGAR
- 2026-09-01 09:26 ET
- Event date
- 2026-09-01
- Accession no.
- 0001140361-26-035195
- Original filing
- SEC EDGAR filing index
Items reported
- Item 1.02: Termination of a Material Definitive Agreement
A material agreement was terminated other than by expiring on its stated date. The company describes the agreement, the circumstances of the termination and any material early-termination penalties. - Item 2.01: Completion of Acquisition or Disposition of Assets
The company completed the acquisition or disposition of a significant amount of assets, including a business. The report covers the date, the assets, the counterparty and the consideration. - Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
The company received notice from its exchange that it does not satisfy a continued listing rule (for example a minimum bid price or filing requirement), or it decided to delist or transfer its listing. - Item 3.03: Material Modifications to Rights of Security Holders
The rights of holders of a class of the company's securities were materially modified, for example by a charter amendment, a rights plan or a reverse stock split. - Item 5.01: Changes in Control of Registrant
A change in control of the company occurred, for example through an acquisition of a controlling stake. - Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
A director or a named officer (such as the CEO or CFO) left or was appointed, or certain executive compensation arrangements were adopted or changed. - Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
The company amended its articles of incorporation or bylaws without a shareholder vote that was previously disclosed, or changed its fiscal year. - Item 9.01: Financial Statements and Exhibits
Lists the financial statements, pro forma information and exhibits filed with the report. It almost always accompanies another Item and is rarely news on its own.
Documents
| Type | Description | Document |
|---|---|---|
| 8-K | 8-K | ef20081409_8k.htm |
| EX-3.1 | EXHIBIT 3.1 | ef20081409_ex3-1.htm |
| EX-3.2 | EXHIBIT 3.2 | ef20081409_ex3-2.htm |
This page lists what the filing reports; it does not summarize or interpret it. Read the original documents on SEC EDGAR. How to read an 8-K.